Alzheimer’s sufferers given hope by new generation of drugs

There is a new class of drug that disrupt and can reverse the build up of the aggregated proteins that lead to Alzheimer's disease.

The drug is in final clinical trials in the UK and, if successful, will be available in 4-5 years.

Here is a brief video that explains how the drug targets the protein responsible for the aggregates:

http://link.brightcove.com/services/link/bcpid1488655367/bctid1697193507

and an article that discusses the new drug:

It is said to be more than twice as effective as current treatments.

A daily capsule of rember, as the drug is known, stops Alzheimer’s disease progressing by as much as 81 per cent, according to trial results.

Patients with the brain disorder had no significant decline in their mental function over a 19-month period.

‘We appear to be bringing the worst affected parts of the brain functionally back to life,’ said Dr Claude Wischik, who led the research.